Mary S. Bradley

1.2k citations
10 papers · 681 indexed · 1 hit paper · h-index 6
Topics
Asthma and respiratory diseases (7 papers)Respiratory and Cough-Related Research (4 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers)

In The Last Decade

Mary S. Bradley

9 papers receiving 669 citations

Hit Papers

Efficacy and Safety of Omalizumab in Patients with Chroni...20142026201820222014100200300

Peers

Mary S. Bradley
Comparison fields: 5 of 36
  • Rheumatology 365
  • Physiology 356
  • Genetics 208
  • Immunology and Allergy 200
  • Pathology and Forensic Medicine 196
Replace Abdelkader Rahmaoui with:
Abdelkader Rahmaoui United States
Pavel Novikov Russia
C Seigneuric France
Martin Plaisance Canada
R Scorza Italy
H Pellet France
Michael Batley United Kingdom
M. Hamidou France
M G Ridley United Kingdom
Chiara Marvisi Italy
Mary S. Bradley relative to Abdelkader Rahmaoui United States Abdelkader Rahmaoui's profile →
Citations per field
00.5×1.5×
Abdelkader Rahmaoui · 1×
Citations per year

Countries citing papers authored by Mary S. Bradley

Since Specialization
Citations

This map shows the geographic impact of Mary S. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary S. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary S. Bradley more than expected).

Fields of papers citing papers by Mary S. Bradley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary S. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary S. Bradley. The network helps show where Mary S. Bradley may publish in the future.

Co-authorship network of co-authors of Mary S. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Mary S. Bradley. A scholar is included among the top collaborators of Mary S. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary S. Bradley. Mary S. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 80
2 73
3 150
4
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Studybreakdown →
307
5 1
6 24
7 2
8 0
9
Omalizumab and malignancy: Interim results from the EXCELS study
4
10 40

About Mary S. Bradley

Mary S. Bradley is a scholar working on Immunology and Allergy, Physiology and Genetics, having authored 10 papers that have together received 681 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Immunology and Allergy (200 citations), Rheumatology (365 citations) and Genetics (208 citations). Mary S. Bradley has collaborated with scholars based in United States, Denmark and Romania. Frequent co-authors include Abdelkader Rahmaoui, Karin Rosén, Mark D. Eisner, Emel Bülbül Başkan, Jean‐Jacques Grob, Oral Alpan, Sarbjit S. Saini, Janice Canvin, Sheldon L. Spector and Panayiotis Georgiou. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Respiratory Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026